Mirati Therapeutics announces pricing of public offering of common stock
Mirati Therapeutics announced pricing of an underwritten public offering of 2,100,000 shares of its common stock at a price to the public of $97.00 per share. Mirati granted underwriters a 30-day option to purchase up to an additional 315,000 shares of common stock. June 25, 2019